Viewing Study NCT00002120


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-05-29 @ 5:59 AM
Study NCT ID: NCT00002120
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia
Sponsor: U.S. Bioscience
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pneumonia, Pneumocystis Carinii View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Trimethoprim-Sulfamethoxazole Combination View
None Trimetrexate View
None Pneumonia, Pneumocystis carinii View
None Leucovorin View
None Dapsone View
None Drug Therapy, Combination View
None Acquired Immunodeficiency Syndrome View